The below table contains a list of reported 'phosphovariants' in the literature. We define a phosphovariant as an amino acid variant that causes a change in phosphorylation status either of the mutant residue, or an adjacent residue. The change in status can either be a 'loss' (ordinary phosphorylation is lost) or 'gain' (a phosphorylation site is gained). For the variants in the table, the referenced studies have shown through in vitro or in vivo studies that the variant causes loss or gain of a specific phosphorylation site. 

^Gene ^Variant ^Phos. site ^Effect ^Reference ^
|Cyclin D1 |T286R |T286 |loss |Benzeno et al. (2006) Oncogene, 25(47), 6291–630 |
|hOG1 |S326C |S326 |loss |Luna et al. (2005) Nucleic Acids Res., 33(6), 1813–1824|
|TP53 |P47S |S46 |loss |Li et al. (2005) J. Biol. Chem., 280(25), 24245–24251|
|TP53 |R213Q |S215 |loss |Wagih et al. (2015) Nat. Meth., 12(6), 531–533|
|TP53 |R282Q |T284 |loss |Wagih et al. (2015) Nat. Meth., 12(6), 531–533|
|BDNF |V66M |T62 |loss |Deng et al. (2013) J. Bone Miner. Res., 28(12), 2498–2507|
|CDKN1A |D149G |S146 |loss |Oh et al. (2007) Apoptosis, 12(7), 1339–1347|
|hERG1 |K897T |T897 |gain |Gentile et al. (2008) Proc. Natl. Acad. Sci. U. S. A., 105(38), 14704–14708|
|PPARG |P113Q |S112 |loss |Ristow et al. (1998) N. Engl. J. Med., 339(14), 953–959|
|PTP-1B |P387L |S386 |loss |Echwald et al. (2002) Diabetes, 51(1), 1–6|
|UBE3A |T485A |T485 |loss |Yi et al. (2015) Cell, 162(4), 795 – 807|
|PER2 |S662G |S662 |loss |Toh et al. (2001) Science, 291(5506), 1040–1043|
|MeCP2 |R306C |T308 |loss |Ebert et al. (2013) Nature, 499(7458), 341–345|
|NKX3-1 |R52C |S48 |loss |Gelmann et al. (2002) Cancer Res., 62(9),2654–2659|
|PLN |R14C |S16 |loss |Ceholski et al. (2012) J. Biol. Chem., 287(32), 26596–26605|
|ABCB4 |T34M |T34 |loss |Gautherot et al. (2014) Hepatology, 60(2), 610–621|
|MAF |P59H |T58 |loss |Niceta et al. (2015) Am. J. Hum. Genet., 96(5), 816 – 825|
|GLUT1 |R223W |S226 |loss |Lee et al. (2015) Mol. Cell, 58(5), 845 – 853|
|AR |R405S |S405 |gain |Lagarde et al. (2012) J. Biol. Chem., 287(14), 10905–10915|
|Gab1 |T387N |S387 |loss |Ortiz-Padilla et al. (2013) Oncogene, 32(21), 2696–2702|
|STAT1 |L706S |Y701 |loss |Dupuis et al. (2001) Science, 293(5528), 300–303|
|CLIP1 |E1012K |S1009 |loss |Wagih et al. (2015) Nat. Meth., 12(6), 531–533|
|CTNNB1 |S37C |S33 |loss |Wagih et al. (2015) Nat. Meth., 12(6), 531–533|
|CTNNB1 |G34R |S47 |gain |Wagih et al. (2015) Nat. Meth., 12(6), 531–533|